3rd CML-CAB: Frankfurt, Germany, 29-30 May 2017

On 29-30 May 2017, the CML Community Advisory Board (CML-CAB), a workgroup of the CML Advocates Network hosted its third meeting to discuss issues of major concern to the CML community. The meeting was made up of 4 sessions: Novartis, BMS, Pfizer, Incyte. The non-confidential minutes of the 1st session are available here.